Answers are grounded in this paper and cite their sources.
Phase I (P1) clinical trials play an important part in management of cancer patients with limited time and treatment options. Time Toxicity (TT), defined as the time (days) spent in contact with the healthcare system, is an important consideration. This study examined TT and its impact on the quality of life (QOL) of patients enrolled in P1 cancer trials.
No takes yet. Share an insight, caveat, or question.
Rajvi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: